Collaboration, partnership, and clinical integration are key.

Myriad Genetics delivered a solid Q4 2025 earnings beat, with positive adjusted EPS and strong test volume growth. Click for my earnings analysis of MYGN stock.

That's not a fringe concern, and it's documented science. Research into cannabis chemovars and chemotypes has consistently shown ...

Access the direct link to download Maharashtra HSC Class 12 Biology Model Question Paper 2026 for board exam preparation from ...

In the book "What We Inherit," experts unpack long-standing myths about genes and how those myths could shape public opinion around emerging embryo-selection technologies.